APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lung AI-assisted Diagnosis Software

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lung AI-assisted Diagnosis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

6 March 2026195 pages

Choose your research edition.

Industry ResearchLung AI-assisted Diagnosis Software Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Lung AI-assisted Diagnosis Software Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Lung AI-assisted Diagnosis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lung AI-assisted Diagnosis Software Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lung AI-assisted Diagnosis Software Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Lung AI-assisted Diagnosis Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Lung AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lung AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lung AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lung AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lung AI-assisted Diagnosis Software include Sense Time, United Imaging, Huiying Medical, Yizhun, BioMind, Shukun, Infervision, Deepwise and Optellum, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Lung AI-assisted Diagnosis Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lung AI-assisted Diagnosis Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lung AI-assisted Diagnosis Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Lung AI-assisted Diagnosis Software market size, projected growth trends, production technologies, key applications, and end-use industries.

Lung AI-assisted Diagnosis Software Segment by Company

Sense Time

United Imaging

Huiying Medical

Yizhun

BioMind

Shukun

Infervision

Deepwise

Optellum

IMLINCS

NeuMiva

Yitu

FOSUN AITROX

VoxelCloud

Lung AI-assisted Diagnosis Software Segment by Type

Public Cloud

Private Cloud

Lung AI-assisted Diagnosis Software Segment by Application

Hospital

Clinic

Imaging Center

Lung AI-assisted Diagnosis Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lung AI-assisted Diagnosis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lung AI-assisted Diagnosis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lung AI-assisted Diagnosis Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Lung AI-assisted Diagnosis Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lung AI-assisted Diagnosis Software industry.

Chapter 3: Detailed analysis of Lung AI-assisted Diagnosis Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lung AI-assisted Diagnosis Softwarerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lung AI-assisted Diagnosis Software Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Public Cloud Table 3. Key Players of Private Cloud Table 4. Global Lung AI-assisted Diagnosis Software Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Imaging Center Table 8. Global Lung AI-assisted Diagnosis Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Lung AI-assisted Diagnosis Software Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Lung AI-assisted Diagnosis Software Market Share by Region (2021-2026) Table 11. Global Lung AI-assisted Diagnosis Software Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Lung AI-assisted Diagnosis Software Market Share by Region (2027-2032) Table 13. Lung AI-assisted Diagnosis Software Industry Trends Table 14. Lung AI-assisted Diagnosis Software Industry Drivers Table 15. Lung AI-assisted Diagnosis Software Industry Opportunities and Challenges Table 16. Lung AI-assisted Diagnosis Software Industry Restraints Table 17. Global Lung AI-assisted Diagnosis Software Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Lung AI-assisted Diagnosis Software Revenue Market Share by Company (2021-2026) Table 19. Global Lung AI-assisted Diagnosis Software Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Lung AI-assisted Diagnosis Software Key Company Head Office and Area Served Table 21. Global Lung AI-assisted Diagnosis Software Company, Product Type & Application Table 22. Global Lung AI-assisted Diagnosis Software Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Lung AI-assisted Diagnosis Software by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Lung AI-assisted Diagnosis Software Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Lung AI-assisted Diagnosis Software Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Lung AI-assisted Diagnosis Software Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Lung AI-assisted Diagnosis Software Revenue Market Share by Type (2021-2026) Table 29. Global Lung AI-assisted Diagnosis Software Revenue Market Share by Type (2027-2032) Table 30. Global Lung AI-assisted Diagnosis Software Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Lung AI-assisted Diagnosis Software Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Lung AI-assisted Diagnosis Software Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Lung AI-assisted Diagnosis Software Revenue Market Share by Application (2021-2026) Table 34. Global Lung AI-assisted Diagnosis Software Revenue Market Share by Application (2027-2032) Table 35. Sense Time Company Information Table 36. Sense Time Business Overview Table 37. Sense Time Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Sense Time Lung AI-assisted Diagnosis Software Product Portfolio Table 39. Sense Time Recent Development Table 40. United Imaging Company Information Table 41. United Imaging Business Overview Table 42. United Imaging Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. United Imaging Lung AI-assisted Diagnosis Software Product Portfolio Table 44. United Imaging Recent Development Table 45. Huiying Medical Company Information Table 46. Huiying Medical Business Overview Table 47. Huiying Medical Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Huiying Medical Lung AI-assisted Diagnosis Software Product Portfolio Table 49. Huiying Medical Recent Development Table 50. Yizhun Company Information Table 51. Yizhun Business Overview Table 52. Yizhun Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Yizhun Lung AI-assisted Diagnosis Software Product Portfolio Table 54. Yizhun Recent Development Table 55. BioMind Company Information Table 56. BioMind Business Overview Table 57. BioMind Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. BioMind Lung AI-assisted Diagnosis Software Product Portfolio Table 59. BioMind Recent Development Table 60. Shukun Company Information Table 61. Shukun Business Overview Table 62. Shukun Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Shukun Lung AI-assisted Diagnosis Software Product Portfolio Table 64. Shukun Recent Development Table 65. Infervision Company Information Table 66. Infervision Business Overview Table 67. Infervision Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Infervision Lung AI-assisted Diagnosis Software Product Portfolio Table 69. Infervision Recent Development Table 70. Deepwise Company Information Table 71. Deepwise Business Overview Table 72. Deepwise Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Deepwise Lung AI-assisted Diagnosis Software Product Portfolio Table 74. Deepwise Recent Development Table 75. Optellum Company Information Table 76. Optellum Business Overview Table 77. Optellum Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Optellum Lung AI-assisted Diagnosis Software Product Portfolio Table 79. Optellum Recent Development Table 80. IMLINCS Company Information Table 81. IMLINCS Business Overview Table 82. IMLINCS Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. IMLINCS Lung AI-assisted Diagnosis Software Product Portfolio Table 84. IMLINCS Recent Development Table 85. NeuMiva Company Information Table 86. NeuMiva Business Overview Table 87. NeuMiva Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. NeuMiva Lung AI-assisted Diagnosis Software Product Portfolio Table 89. NeuMiva Recent Development Table 90. Yitu Company Information Table 91. Yitu Business Overview Table 92. Yitu Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Yitu Lung AI-assisted Diagnosis Software Product Portfolio Table 94. Yitu Recent Development Table 95. FOSUN AITROX Company Information Table 96. FOSUN AITROX Business Overview Table 97. FOSUN AITROX Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. FOSUN AITROX Lung AI-assisted Diagnosis Software Product Portfolio Table 99. FOSUN AITROX Recent Development Table 100. VoxelCloud Company Information Table 101. VoxelCloud Business Overview Table 102. VoxelCloud Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. VoxelCloud Lung AI-assisted Diagnosis Software Product Portfolio Table 104. VoxelCloud Recent Development Table 105. North America Lung AI-assisted Diagnosis Software Market Size by Type (2021-2026) & (US$ Million) Table 106. North America Lung AI-assisted Diagnosis Software Market Size by Type (2027-2032) & (US$ Million) Table 107. North America Lung AI-assisted Diagnosis Software Market Size by Application (2021-2026) & (US$ Million) Table 108. North America Lung AI-assisted Diagnosis Software Market Size by Application (2027-2032) & (US$ Million) Table 109. North America Lung AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Lung AI-assisted Diagnosis Software Market Size by Country (2021-2026) Table 111. North America Lung AI-assisted Diagnosis Software Market Size by Country (2027-2032) Table 112. Europe Lung AI-assisted Diagnosis Software Market Size by Type (2021-2026) & (US$ Million) Table 113. Europe Lung AI-assisted Diagnosis Software Market Size by Type (2027-2032) & (US$ Million) Table 114. Europe Lung AI-assisted Diagnosis Software Market Size by Application (2021-2026) & (US$ Million) Table 115. Europe Lung AI-assisted Diagnosis Software Market Size by Application (2027-2032) & (US$ Million) Table 116. Europe Lung AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Lung AI-assisted Diagnosis Software Market Size by Country (2021-2026) Table 118. Europe Lung AI-assisted Diagnosis Software Market Size by Country (2027-2032) Table 119. China Lung AI-assisted Diagnosis Software Market Size by Type (2021-2026) & (US$ Million) Table 120. China Lung AI-assisted Diagnosis Software Market Size by Type (2027-2032) & (US$ Million) Table 121. China Lung AI-assisted Diagnosis Software Market Size by Application (2021-2026) & (US$ Million) Table 122. China Lung AI-assisted Diagnosis Software Market Size by Application (2027-2032) & (US$ Million) Table 123. Asia Lung AI-assisted Diagnosis Software Market Size by Type (2021-2026) & (US$ Million) Table 124. Asia Lung AI-assisted Diagnosis Software Market Size by Type (2027-2032) & (US$ Million) Table 125. Asia Lung AI-assisted Diagnosis Software Market Size by Application (2021-2026) & (US$ Million) Table 126. Asia Lung AI-assisted Diagnosis Software Market Size by Application (2027-2032) & (US$ Million) Table 127. Asia Lung AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Lung AI-assisted Diagnosis Software Market Size by Country (2021-2026) Table 129. Asia Lung AI-assisted Diagnosis Software Market Size by Country (2027-2032) Table 130. South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size by Type (2021-2026) & (US$ Million) Table 131. South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size by Type (2027-2032) & (US$ Million) Table 132. South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size by Application (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size by Application (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size by Country (2021-2026) Table 136. South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size by Country (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Lung AI-assisted Diagnosis Software Product Image Figure 2. Global Lung AI-assisted Diagnosis Software Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Lung AI-assisted Diagnosis Software Market Share by Type: 2025 VS 2032 Figure 4. Public Cloud Image Figure 5. Private Cloud Image Figure 6. Global Lung AI-assisted Diagnosis Software Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Lung AI-assisted Diagnosis Software Market Share by Application: 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Imaging Center Image Figure 11. Global Lung AI-assisted Diagnosis Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 13. Global Lung AI-assisted Diagnosis Software Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Lung AI-assisted Diagnosis Software Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Lung AI-assisted Diagnosis Software Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Lung AI-assisted Diagnosis Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Lung AI-assisted Diagnosis Software Revenue Market Share by Type (2021-2032) Figure 20. Global Lung AI-assisted Diagnosis Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Lung AI-assisted Diagnosis Software Revenue Market Share by Application (2021-2032) Figure 22. North America Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 23. North America Lung AI-assisted Diagnosis Software Market Share by Type (2021-2032) Figure 24. North America Lung AI-assisted Diagnosis Software Market Share by Application (2021-2032) Figure 25. North America Lung AI-assisted Diagnosis Software Market Share by Country (2021-2032) Figure 26. United States Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 27. Canada Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 29. Europe Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 30. Europe Lung AI-assisted Diagnosis Software Market Share by Type (2021-2032) Figure 31. Europe Lung AI-assisted Diagnosis Software Market Share by Application (2021-2032) Figure 32. Europe Lung AI-assisted Diagnosis Software Market Share by Country (2021-2032) Figure 33. Germany Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 34. France Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 36. Italy Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 37. Russia Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 39. China Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 40. China Lung AI-assisted Diagnosis Software Market Share by Type (2021-2032) Figure 41. China Lung AI-assisted Diagnosis Software Market Share by Application (2021-2032) Figure 42. Asia Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 43. Asia Lung AI-assisted Diagnosis Software Market Share by Type (2021-2032) Figure 44. Asia Lung AI-assisted Diagnosis Software Market Share by Application (2021-2032) Figure 45. Asia Lung AI-assisted Diagnosis Software Market Share by Country (2021-2032) Figure 46. Japan Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 50. India Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 51. Australia Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Share by Country (2021-2032) Figure 56. Brazil Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 61. UAE Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 63. Chile Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Public Cloud
  • Private Cloud
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Sense Time
  • United Imaging
  • Huiying Medical
  • Yizhun
  • BioMind
  • Shukun
  • Infervision
  • Deepwise
  • Optellum
  • IMLINCS
  • NeuMiva
  • Yitu
  • FOSUN AITROX
  • VoxelCloud

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Lung AI-assisted Diagnosis Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Public Cloud
  5. 1.2.3 Private Cloud
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Lung AI-assisted Diagnosis Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Imaging Center
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Lung AI-assisted Diagnosis Software Growth Trends by Region
  13. 1.5.1 Global Lung AI-assisted Diagnosis Software Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Lung AI-assisted Diagnosis Software Market Size by Region (2021-2026)
  15. 1.5.3 Lung AI-assisted Diagnosis Software Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Lung AI-assisted Diagnosis Software Market Dynamics
  1. 2.1 Lung AI-assisted Diagnosis Software Industry Trends
  2. 2.2 Lung AI-assisted Diagnosis Software Industry Drivers
  3. 2.3 Lung AI-assisted Diagnosis Software Industry Opportunities and Challenges
  4. 2.4 Lung AI-assisted Diagnosis Software Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Lung AI-assisted Diagnosis Software Revenue by Company (2021-2026)
  2. 3.2 Global Lung AI-assisted Diagnosis Software Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Lung AI-assisted Diagnosis Software Key Company Head office and Area Served
  4. 3.4 Global Lung AI-assisted Diagnosis Software Company, Product Type & Application
  5. 3.5 Global Lung AI-assisted Diagnosis Software Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Lung AI-assisted Diagnosis Software Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Lung AI-assisted Diagnosis Software Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Lung AI-assisted Diagnosis Software Tier 1, Tier 2, and Tier 3
4 Lung AI-assisted Diagnosis Software Market by Type
  1. 4.1 Global Lung AI-assisted Diagnosis Software Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Lung AI-assisted Diagnosis Software Market Size by Type (2021-2032)
  3. 4.3 Global Lung AI-assisted Diagnosis Software Market Size Share by Type (2021-2032)
5 Lung AI-assisted Diagnosis Software Market by Application
  1. 5.1 Global Lung AI-assisted Diagnosis Software Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Lung AI-assisted Diagnosis Software Market Size by Application (2021-2032)
  3. 5.3 Global Lung AI-assisted Diagnosis Software Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sense Time
  2. 6.1.1 Sense Time Company Information
  3. 6.1.2 Sense Time Business Overview
  4. 6.1.3 Sense Time Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sense Time Lung AI-assisted Diagnosis Software Product Portfolio
  6. 6.1.5 Sense Time Recent Developments
  7. 6.2 United Imaging
  8. 6.2.1 United Imaging Company Information
  9. 6.2.2 United Imaging Business Overview
  10. 6.2.3 United Imaging Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 United Imaging Lung AI-assisted Diagnosis Software Product Portfolio
  12. 6.2.5 United Imaging Recent Developments
  13. 6.3 Huiying Medical
  14. 6.3.1 Huiying Medical Company Information
  15. 6.3.2 Huiying Medical Business Overview
  16. 6.3.3 Huiying Medical Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Huiying Medical Lung AI-assisted Diagnosis Software Product Portfolio
  18. 6.3.5 Huiying Medical Recent Developments
  19. 6.4 Yizhun
  20. 6.4.1 Yizhun Company Information
  21. 6.4.2 Yizhun Business Overview
  22. 6.4.3 Yizhun Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Yizhun Lung AI-assisted Diagnosis Software Product Portfolio
  24. 6.4.5 Yizhun Recent Developments
  25. 6.5 BioMind
  26. 6.5.1 BioMind Company Information
  27. 6.5.2 BioMind Business Overview
  28. 6.5.3 BioMind Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 BioMind Lung AI-assisted Diagnosis Software Product Portfolio
  30. 6.5.5 BioMind Recent Developments
  31. 6.6 Shukun
  32. 6.6.1 Shukun Company Information
  33. 6.6.2 Shukun Business Overview
  34. 6.6.3 Shukun Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Shukun Lung AI-assisted Diagnosis Software Product Portfolio
  36. 6.6.5 Shukun Recent Developments
  37. 6.7 Infervision
  38. 6.7.1 Infervision Company Information
  39. 6.7.2 Infervision Business Overview
  40. 6.7.3 Infervision Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Infervision Lung AI-assisted Diagnosis Software Product Portfolio
  42. 6.7.5 Infervision Recent Developments
  43. 6.8 Deepwise
  44. 6.8.1 Deepwise Company Information
  45. 6.8.2 Deepwise Business Overview
  46. 6.8.3 Deepwise Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Deepwise Lung AI-assisted Diagnosis Software Product Portfolio
  48. 6.8.5 Deepwise Recent Developments
  49. 6.9 Optellum
  50. 6.9.1 Optellum Company Information
  51. 6.9.2 Optellum Business Overview
  52. 6.9.3 Optellum Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Optellum Lung AI-assisted Diagnosis Software Product Portfolio
  54. 6.9.5 Optellum Recent Developments
  55. 6.10 IMLINCS
  56. 6.10.1 IMLINCS Company Information
  57. 6.10.2 IMLINCS Business Overview
  58. 6.10.3 IMLINCS Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 IMLINCS Lung AI-assisted Diagnosis Software Product Portfolio
  60. 6.10.5 IMLINCS Recent Developments
  61. 6.11 NeuMiva
  62. 6.11.1 NeuMiva Company Information
  63. 6.11.2 NeuMiva Business Overview
  64. 6.11.3 NeuMiva Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 NeuMiva Lung AI-assisted Diagnosis Software Product Portfolio
  66. 6.11.5 NeuMiva Recent Developments
  67. 6.12 Yitu
  68. 6.12.1 Yitu Company Information
  69. 6.12.2 Yitu Business Overview
  70. 6.12.3 Yitu Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Yitu Lung AI-assisted Diagnosis Software Product Portfolio
  72. 6.12.5 Yitu Recent Developments
  73. 6.13 FOSUN AITROX
  74. 6.13.1 FOSUN AITROX Company Information
  75. 6.13.2 FOSUN AITROX Business Overview
  76. 6.13.3 FOSUN AITROX Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 FOSUN AITROX Lung AI-assisted Diagnosis Software Product Portfolio
  78. 6.13.5 FOSUN AITROX Recent Developments
  79. 6.14 VoxelCloud
  80. 6.14.1 VoxelCloud Company Information
  81. 6.14.2 VoxelCloud Business Overview
  82. 6.14.3 VoxelCloud Lung AI-assisted Diagnosis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 VoxelCloud Lung AI-assisted Diagnosis Software Product Portfolio
  84. 6.14.5 VoxelCloud Recent Developments
7 North America
  1. 7.1 North America Lung AI-assisted Diagnosis Software Market Size (2021-2032)
  2. 7.2 North America Lung AI-assisted Diagnosis Software Market Size by Type
  3. 7.2.1 North America Lung AI-assisted Diagnosis Software Market Size by Type (2021-2026)
  4. 7.2.2 North America Lung AI-assisted Diagnosis Software Market Size by Type (2027-2032)
  5. 7.2.3 North America Lung AI-assisted Diagnosis Software Market Share by Type (2021-2032)
  6. 7.3 North America Lung AI-assisted Diagnosis Software Market Size by Application
  7. 7.3.1 North America Lung AI-assisted Diagnosis Software Market Size by Application (2021-2026)
  8. 7.3.2 North America Lung AI-assisted Diagnosis Software Market Size by Application (2027-2032)
  9. 7.3.3 North America Lung AI-assisted Diagnosis Software Market Share by Application (2021-2032)
  10. 7.4 North America Lung AI-assisted Diagnosis Software Market Size by Country
  11. 7.4.1 North America Lung AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Lung AI-assisted Diagnosis Software Market Size by Country (2021-2026)
  13. 7.4.3 North America Lung AI-assisted Diagnosis Software Market Size by Country (2027-2032)
  14. 7.4.4 North America Lung AI-assisted Diagnosis Software Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Lung AI-assisted Diagnosis Software Market Size (2021-2032)
  2. 8.2 Europe Lung AI-assisted Diagnosis Software Market Size by Type
  3. 8.2.1 Europe Lung AI-assisted Diagnosis Software Market Size by Type (2021-2026)
  4. 8.2.2 Europe Lung AI-assisted Diagnosis Software Market Size by Type (2027-2032)
  5. 8.2.3 Europe Lung AI-assisted Diagnosis Software Market Share by Type (2021-2032)
  6. 8.3 Europe Lung AI-assisted Diagnosis Software Market Size by Application
  7. 8.3.1 Europe Lung AI-assisted Diagnosis Software Market Size by Application (2021-2026)
  8. 8.3.2 Europe Lung AI-assisted Diagnosis Software Market Size by Application (2027-2032)
  9. 8.3.3 Europe Lung AI-assisted Diagnosis Software Market Share by Application (2021-2032)
  10. 8.4 Europe Lung AI-assisted Diagnosis Software Market Size by Country
  11. 8.4.1 Europe Lung AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Lung AI-assisted Diagnosis Software Market Size by Country (2021-2026)
  13. 8.4.3 Europe Lung AI-assisted Diagnosis Software Market Size by Country (2027-2032)
  14. 8.4.4 Europe Lung AI-assisted Diagnosis Software Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Lung AI-assisted Diagnosis Software Market Size (2021-2032)
  2. 9.2 China Lung AI-assisted Diagnosis Software Market Size by Type
  3. 9.2.1 China Lung AI-assisted Diagnosis Software Market Size by Type (2021-2026)
  4. 9.2.2 China Lung AI-assisted Diagnosis Software Market Size by Type (2027-2032)
  5. 9.2.3 China Lung AI-assisted Diagnosis Software Market Share by Type (2021-2032)
  6. 9.3 China Lung AI-assisted Diagnosis Software Market Size by Application
  7. 9.3.1 China Lung AI-assisted Diagnosis Software Market Size by Application (2021-2026)
  8. 9.3.2 China Lung AI-assisted Diagnosis Software Market Size by Application (2027-2032)
  9. 9.3.3 China Lung AI-assisted Diagnosis Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Lung AI-assisted Diagnosis Software Market Size (2021-2032)
  2. 10.2 Asia Lung AI-assisted Diagnosis Software Market Size by Type
  3. 10.2.1 Asia Lung AI-assisted Diagnosis Software Market Size by Type (2021-2026)
  4. 10.2.2 Asia Lung AI-assisted Diagnosis Software Market Size by Type (2027-2032)
  5. 10.2.3 Asia Lung AI-assisted Diagnosis Software Market Share by Type (2021-2032)
  6. 10.3 Asia Lung AI-assisted Diagnosis Software Market Size by Application
  7. 10.3.1 Asia Lung AI-assisted Diagnosis Software Market Size by Application (2021-2026)
  8. 10.3.2 Asia Lung AI-assisted Diagnosis Software Market Size by Application (2027-2032)
  9. 10.3.3 Asia Lung AI-assisted Diagnosis Software Market Share by Application (2021-2032)
  10. 10.4 Asia Lung AI-assisted Diagnosis Software Market Size by Country
  11. 10.4.1 Asia Lung AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Lung AI-assisted Diagnosis Software Market Size by Country (2021-2026)
  13. 10.4.3 Asia Lung AI-assisted Diagnosis Software Market Size by Country (2027-2032)
  14. 10.4.4 Asia Lung AI-assisted Diagnosis Software Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Lung AI-assisted Diagnosis Software Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst